Seikagaku Corporation (TYO:4548)

Japan flag Japan · Delayed Price · Currency is JPY
722.00
+5.00 (0.70%)
Jan 23, 2026, 3:30 PM JST
-7.44%
Market Cap39.42B
Revenue (ttm)37.07B
Net Income (ttm)-488.00M
Shares Out54.60M
EPS (ttm)-8.94
PE Ration/a
Forward PEn/a
Dividend30.00 (4.18%)
Ex-Dividend DateMar 30, 2026
Volume116,400
Average Volume145,465
Open717.00
Previous Close717.00
Day's Range712.00 - 724.00
52-Week Range603.00 - 802.00
Beta0.17
RSI60.35
Earnings DateFeb 6, 2026

About Seikagaku

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. It operates in two segments, Pharmaceuticals and LAL Business. The company offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand nam... [Read more]

Sector Healthcare
Founded 1947
Employees 1,075
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4548
Full Company Profile

Financial Performance

In 2024, Seikagaku's revenue was 39.37 billion, an increase of 8.73% compared to the previous year's 36.21 billion. Earnings were 1.21 billion, a decrease of -44.46%.

Financial Statements